Pharmacy and Poisons Board

Pharmacy and Poisons Board

Ensuring Safety, Quality and Efficacy of Medicines

Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 1 of 6, showing 5 Applications out of 27 total, starting on record 1, ending on 5

# Protocol No Study Title Investigator(s) & Site(s) Application Status

1.

ECCT/10/03/03   High-Dose Fluconazole Treatment in AIDS-Associated CM
    A5225/HiFLAC: A Phase I/II Dose-Finding Study of High-Dose Fluconazole Treatment in AIDS-Associated Cryptococcal Meningitis   
Principal Investigator(s)
1. Abraham Mosigisi Siika
Site(s) in Kenya
1. Moi University Clinical Research Centre (Uasin Gishu county)
 
Trial Status completed
Protocol Date 11-05-2012
View

2.

ECCT/10/09/05  
    A Phase I/II Dose-Finding Study of High-Dose Fluconazole Treatment in AIDS-Associated Cryptococcal Meningitis       A Multicenter Trial of the AIDS Clinical Trials Group (ACTG)   
Principal Investigator(s)
1. Deborah Chepng\'eno langat
Site(s) in Kenya
KEMRI/Walter Reed Project
 
Trial Status Analysing
Protocol Date 11-05-2012
View

3.

ECCT/11/12/01   IAVI B004
    A Phase 1 Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of a Multiantigen HIV (HIV-MAG) plasmid DNA (pDNA) Vaccine co-administered with Recombinant Human IL-12 pDNA (GENEVAX® IL-12) followed or preceded by Recombinant Ad35-GRIN/ENV HIV Vaccine in HIV-Uninfected, Healthy Volunteers   
Principal Investigator(s)
1. OMU ANZALA
Site(s) in Kenya
Kenya AIDS Vaccine Initiative -Kangemi Clinic
 
Trial Status Analysing
Protocol Date 30-06-2011
View

4.

ECCT/11/12/04   PENNVAX-G DNA/MVA HIV Vaccine Phase 1 trial
    A Phase I Study of the Safety and Immunogenicity of PENNVAX™-G DNA (Env & Gag) Administered by Intramuscular Biojector® 2000 or by CELLECTRA® Intramuscular Electroporation Device Followed by MVACMDR (HIV-1 CM235 env/ CM240 gag/pol) Boost in Healthy, HIV Uninfected Adults   
Principal Investigator(s)
1. FREDRICK KIPYEGO SAWE
Site(s) in Kenya
KEMRI/Walter Reed Project-Kericho
 
Trial Status In follow-up
Protocol Date 20-01-2011
View

5.

ECCT/12/11/02   Not provided
    A5297: An Open-Label, Proof of Concept, Randomized Trial Comparing a LPV/r-Based to an nNRTI-Based Antiretroviral Therapy Regimen for Clearance of   Plasmodium falciparum Subclinical Parasitemia in HIV-infected Adults with CD4+ Counts >200 and <350 cells/mm3   
Principal Investigator(s)
1. Abraham Mosigisi Siika
Site(s) in Kenya
1. Moi University Clinical Research Centre (Uasin Gishu county)
 
Trial Status completed
Protocol Date 29-02-2012
View